VanEck Pharmaceutical ETF
PPH
PPH
54 hedge funds and large institutions have $79M invested in VanEck Pharmaceutical ETF in 2014 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 18 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
1.55%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.09%
New
8
Increased
17
Reduced
18
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Goldman Sachs
New York
|
+$12.5M |
2 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
+$7.5M |
3 |
HighTower Advisors
Chicago,
Illinois
|
+$2.94M |
4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$2.45M |
5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$1.49M |
Top Sellers
1 |
MA
Montag & Associates
Atlanta,
Georgia
|
-$1.57M |
2 |
VF
Virtu Financial
New York
|
-$1.5M |
3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.17M |
4 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
-$618K |
5 |
Citadel Advisors
Miami,
Florida
|
-$394K |